This inventor holds 1 USPTO granted patent. Top assignee: Shanghai Abelzeta Ltd.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Innovations by Shenchen Wang in Tumor-Infiltrating Lymphocyte Expansion
Introduction
Shenchen Wang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of cancer research, particularly in the area of tumor-infiltrating lymphocytes (TILs). His innovative methods have the potential to enhance cancer treatment by improving the availability of TILs for therapeutic use.
Latest Patents
Shenchen Wang holds a patent for "Methods for preparing tumor-infiltrating lymphocytes." This patent describes methods for expanding TILs, which include co-culturing an initial cell population containing TILs with first feeder cells to obtain a first expanded cell population. Subsequently, the first expanded cell population is co-cultured with second feeder cells to obtain an expanded TIL population. These methods can quickly produce a large number of TILs from a small tumor sample, which is crucial for effective cancer therapies.
Career Highlights
Shenchen Wang is currently associated with Shanghai Abelzeta Ltd., where he continues to work on innovative solutions in cancer treatment. His research focuses on enhancing the efficacy of TILs, which are vital for immunotherapy approaches in oncology.
Collaborations
Shenchen collaborates with talented individuals such as Jia Li and Jiyan Hou. Their combined expertise contributes to the advancement of research in tumor-infiltrating lymphocytes and cancer therapies.
Conclusion
Shenchen Wang's work in expanding tumor-infiltrating lymphocytes represents a significant advancement in cancer treatment methodologies. His innovative approaches have the potential to improve patient outcomes and further the field of immunotherapy.